US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bone Biologics Corp

35.95

0.0000

Volume:53.00

Turnover:2.12K

Market Cap:- -

PE:-4.93

High:35.95

Open:35.95

Low:35.95

Close:35.95

52wk High:43.95

52wk Low:8.30

Shares:- -

Float Shares:- -

Volume Ratio:0.04

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.2975

ROE:-80.46%

ROA:-48.68%

PB:0.00

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Bone Biologics Corp

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.bonebiologis.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BBLGW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBLGW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBLGW\",,,,,undefined,":{"symbol":"BBLGW","market":"US","secType":"STK","nameCN":"Bone Biologics Corp","latestPrice":35.95,"timestamp":1771951939489,"preClose":35.95,"halted":0,"volume":53,"delay":0,"changeRate":0,"floatShares":0,"shares":0,"eps":-7.2975,"marketStatus":"Closed","change":0,"latestTime":"02-24 11:52:19 EST","open":35.95,"high":35.95,"low":35.95,"amount":2122.04,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.2975,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":5,"adr":0,"listingDate":1634097600000,"exchange":"NASDAQ","adjPreClose":35.95,"volumeRatio":0.044598},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBLGW\",,,,,undefined,":{"symbol":"BBLGW","floatShares":0,"roa":"-48.68%","roe":"-80.46%","lyrEps":0,"volumeRatio":0.044598,"shares":0,"dividePrice":0,"high":35.95,"amplitude":0,"preClose":35.95,"low":35.95,"week52Low":8.3,"pbRate":"0.00","week52High":43.95,"institutionHeld":0,"latestPrice":35.95,"eps":-7.2975,"divideRate":0,"volume":53,"delay":0,"ttmEps":-7.2975,"open":35.95,"prevYearClose":16.18,"prevWeekClose":31.95,"prevMonthClose":15.63,"prevQuarterClose":16.18,"fiveDayClose":32.05,"twentyDayClose":14.46,"sixtyDayClose":23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBLGW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2023-06-07","symbol":"BBLGW","defaultRemindTime":1686144600000,"type":"split","dateTimestamp":1686110400000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBLGW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBLGW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.bonebiologis.com","stockEarnings":[{"period":"1week","weight":0.1597},{"period":"1month","weight":1.1073},{"period":"3month","weight":0.563},{"period":"6month","weight":2.3318},{"period":"1year","weight":0.7284},{"period":"ytd","weight":1.2219}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":1.002972},{"month":2,"riseRate":0.2,"avgChangeRate":-0.048898},{"month":3,"riseRate":0.25,"avgChangeRate":0.422011},{"month":4,"riseRate":0.5,"avgChangeRate":0.296505},{"month":5,"riseRate":0.25,"avgChangeRate":-0.088187},{"month":6,"riseRate":0.75,"avgChangeRate":0.465155},{"month":7,"riseRate":0.5,"avgChangeRate":0.117475},{"month":8,"riseRate":0.5,"avgChangeRate":0.214809},{"month":9,"riseRate":0.25,"avgChangeRate":0.501095},{"month":10,"riseRate":0.25,"avgChangeRate":-0.327664},{"month":11,"riseRate":0.2,"avgChangeRate":-0.185933},{"month":12,"riseRate":0.6,"avgChangeRate":0.63345}],"exchange":"NASDAQ","name":"Bone Biologics Corp","nameEN":"Bone Biologics Corp"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BBLGW\",market:\"US\",,,undefined,":null}}